Se deseja cadastrar seu consultório, clique aqui.
CRIAR CONTA
Criando minha conta, eu concordo com os
Termos e condições.
CRIAR CONTA COM MEU E-MAIL
Criando minha conta, eu concordo com os
Termos e condições.
É você?
Locais de atendimento
Jd Nova Campinas
LOCALIZAÇÃO
Rua Dr Alexander Fleming, 784 - Jd Nova Campinas, Campinas - SP
ESPECIALIDADES ATENDIDAS
Cirurgião Geral, Cirurgião Plástico
CONTATO
Centro
LOCALIZAÇÃO
Avenida Dom Nery, 174 - Centro, Valinhos - SP
ESPECIALIDADES ATENDIDAS
Cirurgião Geral, Cirurgião Plástico
CONTATO
Convênios atendidos
Amil
Publicações
- Paiva B, Amaral CMDO, Domizio GDI, Tiziani V, Galhardi F, Buzzo CL, et al. GRADUAL BONE DISTRACTION IN CRANIOSYNOSTOSIS. PRELIMINARY RESULTS IN SEVEN CASES. 01 de Março de 1997.
- Paiva B, Perez-Andres M, Nieto WG, Caraux A, Schmitz A, Almeida J, et al. HUMAN PERIPHERAL BLOOD B-CELL COMPARTMENTS: A CROSSROAD IN B-CELL TRAFFIC.
- Paiva B, Pérez-Andrés M, Vídriales M-B, Almeida J, Heras NDELAS, Mateos M-V, et al. COMPETITION BETWEEN CLONAL PLASMA CELLS AND NORMAL CELLS FOR POTENTIALLY OVERLAPPING BONE MARROW NICHES IS ASSOCIATED WITH A PROGRESSIVELY ALTERED CELLULAR DISTRIBUTION IN MGUS VS MYELOMA. 01 de Abril de 2011.
- Paiva B, García-Sanz R, Ocio EM, Caballero A, Magalhães RJP, Alonso J, et al. POST-TREATMENT BONE MARROW RESIDUAL DISEASE > 5% BY FLOW CYTOMETRY IS HIGHLY PREDICTIVE OF SHORT PROGRESSION-FREE AND OVERALL SURVIVAL IN PATIENTS WITH WALDENSTRÖM'S MACROGLOBULINEMIA. 01 de Fevereiro de 2011.
- Paiva B, Gutiérrez N-C, Chen X, Vídriales M-B, Montalbán M-Á, Rosiñol L, et al. CLINICAL SIGNIFICANCE OF CD81 EXPRESSION BY CLONAL PLASMA CELLS IN HIGH-RISK SMOLDERING AND SYMPTOMATIC MULTIPLE MYELOMA PATIENTS. 01 de Agosto de 2012.
- Paiva B, Jiménez C, Sebastián E, Chillón MC, Giraldo P, Hernández JMARIANO, et al. MYD88 L265P IS A MARKER HIGHLY CHARACTERISTIC OF, BUT NOT RESTRICTED TO, WALDENSTRÖM'S MACROGLOBULINEMIA. 01 de Agosto de 2013.
- Paiva B, Montes MC, García-Sanz R, Ocio EM, Alonso J, Heras NDELAS, et al. MULTIPARAMETER FLOW CYTOMETRY FOR THE IDENTIFICATION OF THE WALDENSTRÖM'S CLONE IN IGM-MGUS AND WALDENSTRÖM'S MACROGLOBULINEMIA: NEW CRITERIA FOR DIFFERENTIAL DIAGNOSIS AND RISK STRATIFICATION. 01 de Janeiro de 2014.
- Paiva B, Vídriales M-B, Rosiñol L, Martínez-López J, Mateos M-V, Ocio EM, et al. A MULTIPARAMETER FLOW CYTOMETRY IMMUNOPHENOTYPIC ALGORITHM FOR THE IDENTIFICATION OF NEWLY DIAGNOSED SYMPTOMATIC MYELOMA WITH AN MGUS-LIKE SIGNATURE AND LONG-TERM DISEASE CONTROL. 01 de Outubro de 2013.
- Paiva B, Puig N, Sarasquete ME, Balanzategui A, Martínez J, García H, et al. CRITICAL EVALUATION OF ASO RQ-PCR FOR MINIMAL RESIDUAL DISEASE EVALUATION IN MULTIPLE MYELOMA. A COMPARATIVE ANALYSIS WITH FLOW CYTOMETRY. 01 de Fevereiro de 2014.
- Paiva B, Matarraz S, Díez-Campelo M, Bárrena S, Jara-Acevedo M, Gutiérrez ML, et al. IMMUNOPHENOTYPIC ALTERATIONS OF BONE MARROW MYELOID CELL COMPARTMENTS IN MULTIPLE MYELOMA PATIENTS PREDICT FOR MYELODYSPLASIA-ASSOCIATED CYTOGENETIC ALTERATIONS. 01 de Agosto de 2014.
- Paiva B, Paíno T, Sayagués JM, Mota I, Carvalheiro T, Corchete LA, et al. PHENOTYPIC IDENTIFICATION OF SUBCLONES IN MULTIPLE MYELOMA WITH DIFFERENT CHEMORESISTANT, CYTOGENETIC AND CLONOGENIC POTENTIAL. 01 de Maio de 2015.
- Paiva B, Azpilikueta A, Puig N, Ocio EM, Sharma R, Oyajobi BO, et al. PD-L1/PD-1 PRESENCE IN THE TUMOR MICROENVIRONMENT AND ACTIVITY OF PD-1 BLOCKADE IN MULTIPLE MYELOMA. 01 de Outubro de 2015.
- Paiva B, Moschetta M, Mishima Y, Kawano Y, Manier S, Palomera L, et al. TARGETING VASCULOGENESIS TO PREVENT PROGRESSION IN MULTIPLE MYELOMA. 01 de Maio de 2016.
- Paiva B, Puig N, Cedena M-T, Jong BGDE, Ruiz Y, Rapado I, et al. DIFFERENTIATION STAGE OF MYELOMA PLASMA CELLS: BIOLOGICAL AND CLINICAL SIGNIFICANCE. 01 de Agosto de 2016.
(*) Todo o conteúdo desta página foi coletado automaticamente de fontes públicas.